ArticleJuntendo medical journal2026
Relationship Between Patient Activation and Quality of Life in HCN1-Related Epilepsy.
Article in Juntendo medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Epilepsies due to variation of the HCN1 gene can be associated with long-term neurological and psychiatric comorbidities, which may impact daily living. The degree of patient empowerment in managing their disease substantially impacts how they assess QoL. This study aimed to investigate the relationship between patient activation and health-related quality of life (HRQOL) in adults with HCN1-related epilepsies. Materials and Methods: A cross-sectional study was conducted among 403 adult patients with controlled epilepsy attending neurology clinics. Informed consent was taken verbally. Participants completed the Patient Activation Measure (PAM) and Quality of Life in Epilepsy Inventory (QOLIE-31). Descriptive, correlation, and regression analyses were performed using IBM SPSS Statistics version 26. Results: There was a moderate, positive correlation between patient activation and HRQOL (r = 0.412, p < 0.001). PAM scores were higher in females (p < 0.001), and HRQOL is reported to be better by males (p = 0.010). PAM and QOLIE scores differed significantly with age (p < 0.001), with the highest proportions in the 35-44 and ≥55 years age groups, respectively. Regression analysis showed that greater patient activation (B value 1.85, p < 0.001) and older age (B value 0.48, p = 0.017) were positive predictors of HRQOL. At the same time, female gender, later onset of epilepsy and frequency of seizures were negative predictors. Conclusion: Increased patient activation is strongly associated with better HRQOL in HCN1-associated epilepsy. Interventions that enhance patient involvement, self-management, and disease awareness may improve psychosocial and clinical outcomes in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.